Mira is bringing its version of Oxford Cancer Biomarkers' PGx test to the US in the newly launched ToxNav Advantage assay.
XIAN HIGH-TECH AREA, SHAANXI, CHINA, January 19, 2026 /EINPresswire.com/ -- With increasing demands for product ...
Oncology pharmacists bridge gaps in test ordering, result interpretation, and therapy access, ensuring timely and effective ...
Oncomine Dx Express Test on the Ion Torrent Genexus Dx Integrated Sequencer generates results in as little as 24 hours to support timely therapy decisions A patient’s tumor profile has the potential ...
Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. The complexity of software architecture and diverse user interactions presents challenges to ...
Large-scale infrastructure projects, interconnection schemes, and renewable energy developments continue to shape the region’s power landscape. In such projects, even small deviations in CT or PT ...
Acquired CARD11 Mutation Promotes BCR Independence in Diffuse Large B Cell Lymphoma Despite the well-understood benefits of biomarker and genetic testing in precision medicine, uptake remains low, ...